← back to database
Pender Ventures invests in Canadian B2B software and healthtech companies at the inflection point between commercialization and scale. It is stage-agnostic but identifies Series A as its typical sweet spot, prefers to lead priced rounds, and can invest across North America.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
C$100 million+ Pender Technology Inflection Fund II
Latest fund vintage
2024
Investing team
Cheri CorbettPartner
Everett JuurlinkAnalyst
Jacob GraingerAssociate
Lizzie HnatiukAnalyst and AI Lead
Maria PacellaManaging Partner
Meryeme LahmamiPrincipal
How to reach them
Notable investments
Jane App, Clarius Mobile Health, Checkfront, DrugBank, Swift Medical, Copperleaf, DistillerSR, Traction Complete